ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress

194Citations
Citations of this article
335Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We discuss the current status of liquid biopsy and its advantages and challenges with a focus on pre-analytical sample handling, technologies and workflows. The potential of circulating tumor cells and circulating tumor DNA is pointed out and an overview of corresponding technologies is given.

Cite

CITATION STYLE

APA

Neumann, M. H. D., Bender, S., Krahn, T., & Schlange, T. (2018, January 1). ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress. Computational and Structural Biotechnology Journal. Elsevier B.V. https://doi.org/10.1016/j.csbj.2018.05.002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free